Torsade de pointes and low-dose oral haloperidol.
- 22 September 1997
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 157 (17) , 2013-2015
- https://doi.org/10.1001/archinte.1997.00440380123013
Abstract
Haloperidol, used to treat patients with psychoses, is considered minimally cardiotoxic. Several cases of torsade de pointes have been reported in association with the use of oral haloperidol. In each of those cases, a prolonged QTCpreceded the torsade de pointes episode and thus may be considered a predictor for ventricular arrhythmias in elderly women treated with haloperidol. However, the following case may demonstrate the inability to predict an episode of torsade de pointes with low-dose oral haloperidol use. Arch Intern Med. 1997;157:2013-2015This publication has 2 references indexed in Scilit:
- Life-Threatening Ventricular Arrhythmia (Torsades de Pointes) after Haloperidol OverdoseHuman & Experimental Toxicology, 1991
- Torsades de Pointes Ventricular Tachyarrhythmia Associated with HaloperidolJournal of Clinical Psychopharmacology, 1986